Skip to main content
Fig. 2 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 2

From: Role of positron-emission tomography/computed tomography (PET/CT) in breast cancer

Fig. 2

a (1, 2, 3) CECT, fused PET CT, and PET axial images show increase FDG uptake corresponding to lower inner quadrant enhancing mass with speculated margin, the lesion extends to the adjacent skin. It measures 3.7 × 1.8 cm with SUVmax 2.8. b (1, 2, 3) CECT, fused PET CT, and PET axial images show mild marginal increase FDG uptake corresponding to left adrenal mass lesion measuring 5 × 3.7 cm with SUVmax 2.8. (false negative result). c (1, 2, 3) CECT, fused PET CT, and PET axial images show hypodense, non-enhanced segment IV hepatic lesion with no FDG up take. Cystic lesion measuring 4.4 × 2.8 cm. Impression: Metabolically active right breast neoplasm. Mild metabolically active left adrenal mass, possible metastasis. Left hepatic lobe cystic lesion with no FDG uptake

Back to article page